ohm or anyone else knowledgeable: I've been seeing that other mabs that are coming through with good trial results sometimes have 'cytokine release syndrome' as a frequent side effect (with one trial of a combination of talquetamab and talquistamab it was 79%). Would LL be a good addition to that treatment regimen to preclude that effect? Or would it conflict with the action of the other mabs? (I still haven't taken the time to learn how to make links LOL...but those are the two mabs in one study that had the pretty severe AEs)